These anti-cancer effects may be linked to regulating signaling pathways such as the PI3K/AKT signaling pathway [10], the EGFR/Raf signaling pathway [11], the mTOR/AMPK signaling pathway [12], the P53 signaling pathway [13], the Dectin-1/Syk/NF-κB signaling pathway [14], and the TLR4/NF/κ B signaling pathway [15]. The gene discussed is AKT1; the disease is cancer.